-
Je něco špatně v tomto záznamu ?
Epigallocatechin gallate: a review
L. Bartošíková, J. Nečas
Jazyk angličtina Země Česko
Typ dokumentu přehledy
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
Free Medical Journals
od 2001
ProQuest Central
od 2001-01-01
Open Access Digital Library
od 2001-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
- Klíčová slova
- epigalokatechin galát, zelený čaj,
- MeSH
- antiinfekční látky farmakokinetika farmakologie MeSH
- čaj chemie metabolismus toxicita MeSH
- farmakokinetika MeSH
- farmakologie MeSH
- klinická studie jako téma MeSH
- lékové interakce MeSH
- neuroprotektivní látky farmakokinetika farmakologie MeSH
- protinádorové látky farmakokinetika farmakologie MeSH
- testy genotoxicity MeSH
- Publikační typ
- přehledy MeSH
Epigallocatechin gallate is the major component of the polyphenolic fraction of green tea and is responsible for most of the therapeutic benefits of green tea consumption. A number of preclinical in vivo and in vitro experiments as well as clinical trials have shown a wide range of biological and pharmacological properties of polyphenolic compounds such as anti-oxidative, antimicrobial, anti-allergic, anti-diabetic, anti-inflammatory, anti-cancer, chemoprotective, neuroprotective and immunomodulatory effects. Epigallocatechin gallate controls high blood pressure, decreases blood cholesterol and body fat and decreases the risk of osteoporotic fractures. Further research should be performed to monitor the pharmacological and clinical effects of green tea and to more clearly elucidate its mechanisms of action and the potential for its use in medicine.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19006895
- 003
- CZ-PrNML
- 005
- 20210624004701.0
- 007
- cr|cn|
- 008
- 190221s2018 xr d fs 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.17221/31/2018-VETMED $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Bartošíková, Lenka, $d 1968- $7 nlk20020124783 $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 245 10
- $a Epigallocatechin gallate: a review / $c L. Bartošíková, J. Nečas
- 520 3_
- $a Epigallocatechin gallate is the major component of the polyphenolic fraction of green tea and is responsible for most of the therapeutic benefits of green tea consumption. A number of preclinical in vivo and in vitro experiments as well as clinical trials have shown a wide range of biological and pharmacological properties of polyphenolic compounds such as anti-oxidative, antimicrobial, anti-allergic, anti-diabetic, anti-inflammatory, anti-cancer, chemoprotective, neuroprotective and immunomodulatory effects. Epigallocatechin gallate controls high blood pressure, decreases blood cholesterol and body fat and decreases the risk of osteoporotic fractures. Further research should be performed to monitor the pharmacological and clinical effects of green tea and to more clearly elucidate its mechanisms of action and the potential for its use in medicine.
- 650 _2
- $a čaj $x chemie $x metabolismus $x toxicita $7 D013662
- 650 _2
- $a farmakokinetika $7 D010599
- 650 _2
- $a farmakologie $7 D010600
- 650 _2
- $a klinická studie jako téma $7 D000068456
- 650 _2
- $a testy genotoxicity $7 D009152
- 650 _2
- $a lékové interakce $7 D004347
- 650 _2
- $a protinádorové látky $x farmakokinetika $x farmakologie $7 D000970
- 650 _2
- $a antiinfekční látky $x farmakokinetika $x farmakologie $7 D000890
- 650 _2
- $a neuroprotektivní látky $x farmakokinetika $x farmakologie $7 D018696
- 653 00
- $a epigalokatechin galát
- 653 00
- $a zelený čaj
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Nečas, Jiří, $d 1954- $7 nlk19990073608 $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 773 0_
- $t Veterinární medicína $x 0375-8427 $g Roč. 63, č. 10 (2018), s. 443-467 $w MED00177041
- 856 41
- $u https://www.agriculturejournals.cz/publicFiles/31_2018-VETMED.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $y p $z 0
- 990 __
- $a 20190221073206 $b ABA008
- 991 __
- $a 20210624004700 $b ABA008
- 999 __
- $a ok $b bmc $g 1378310 $s 1045129
- BAS __
- $a 3 $a 4
- BMC __
- $a 2018 $b 63 $c 10 $d 443-467 $i 0375-8427 $m Veterinární medicína $x MED00177041
- LZP __
- $c NLK189 $d 20210624 $a NLK 2019-01/pk